to facilitate identification and evaluation of pharma-
ceutical-based agents and by purchasing screening 
technologies for use at international mail facilities. 
(7) Operating the Food and Drug Administra-
tion’s forensic laboratory facility to ensure adequate 
laboratory space and functionality for additional 
work and full-time equivalent employees. 
(e) ACCOUNTABILITY AND OVERSIGHT.— 
(1) WORK PLAN.— 
(A) IN
GENERAL.—Not later than 180 
days after the date of enactment of this Act, 
the Commissioner of Food and Drugs shall sub-
mit to the Committee on Health, Education, 
Labor, and Pensions of the Senate and the 
Committee on Energy and Commerce of the 
House of Representatives, a work plan includ-
ing the proposed allocation of funds appro-
priated pursuant to the authorization of appro-
priations under subsection (c) for each of fiscal 
years 2019 through 2023 and the contents de-
scribed in subparagraph (B). 
(B) CONTENTS.—The work plan submitted 
under subparagraph (A) shall include— 
(i) the amount of money to be obli-
gated or expended out of the Account in 
VerDate Sep 11 2014 
23:09 Mar 19, 2018
Jkt 079200
PO 00000
Frm 00022
Fmt 6652
Sfmt 6201
E:\BILLS\H5228.IH
H5228
sradovich on DSK3GMQ082PROD with BILLS
each fiscal year for each program and ac-
tivity described in subsection (d); and 
(ii) a description and justification of 
each such program and activity. 
(2) REPORTS.— 
(A) ANNUAL
REPORTS.—Not later than 
October 1 of each of fiscal years 2020 through 
2024, the Secretary of Health and Human 
Services shall submit to the Committee on 
Health, Education, Labor, and Pensions of the 
Senate and the Committee on Energy and Com-
merce of the House of Representatives, a report 
including— 
(i) the amount of money obligated or 
expended out of the Account in the prior 
fiscal year for each program and activity 
described in subsection (d); 
(ii) a description of all programs and 
activities using funds provided pursuant to 
the authorization of appropriations under 
subsection (c); and 
(iii) how the programs and activities 
are advancing public health. 
(B) ADDITIONAL
REPORTS.—At the re-
quest of the Committee on Health, Education, 
VerDate Sep 11 2014 
23:09 Mar 19, 2018
Jkt 079200
PO 00000
Frm 00023
Fmt 6652
Sfmt 6201
E:\BILLS\H5228.IH
H5228
sradovich on DSK3GMQ082PROD with BILLS
Labor, and Pensions of the Senate, or the Com-
mittee on Energy and Commerce of the House 
of Representatives, the Commissioner shall pro-
vide an update in the form of testimony and 
any additional reports to the respective congres-
sional committee regarding the allocation of 
funding under this section or the description of 
the programs and activities undertaken with 
such funding. 
(f) LIMITATIONS.—Notwithstanding any transfer au-
thority authorized by this Act or any appropriations Act, 
any funds made available pursuant to the authorization 
of appropriations under subsection (c) may not be used 
for any purpose other than the programs and activities 
described in subsection (d) strengthen and facilitate the 
Food and Drug Administration’s efforts to address the 
opioid and substance use epidemic. 
(g) SUNSET.—This section shall expire on September 
30, 2022, except that— 
(1) this subsection does not apply to reporting 
under subsection (e)(2); and 
(2) this section shall remain in effect until such 
time, and to such extent, as may be necessary for 
VerDate Sep 11 2014 
23:09 Mar 19, 2018
Jkt 079200
PO 00000
Frm 00024
Fmt 6652
Sfmt 6201
E:\BILLS\H5228.IH
H5228
sradovich on DSK3GMQ082PROD with BILLS
the funds transferred by subsection (b)(2) to be fully 
expended. 
Æ 
VerDate Sep 11 2014 
23:09 Mar 19, 2018
Jkt 079200
PO 00000
Frm 00025
Fmt 6652
Sfmt 6301
E:\BILLS\H5228.IH
H5228
sradovich on DSK3GMQ082PROD with BILLS